Loading ...Advice to Practitioners 
Certain H1N1 Vaccines Should Be Given by Feb. 15(0)
All lots of Sanofi Pasteur H1N1 vaccine in prefilled syringes should be administered by February 15 because of concerns over reduced potency, the CDC reported on Wednesday.
Three Studies Demonstrate the Safety and Efficacy of Pandemic H1N1 Flu Vaccine
Results are in from studies in the U.S., China, and Hungary. (more…)
Case 40-2009 — A 29-Year-Old Man with Fever and Respiratory Failure
CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL
Case 40-2009 — A 29-Year-Old Man with Fever and Respiratory Failure
T.M. Uyeki, A. Sharma, and J.A. Branda
A 29-year-old man presented with fever and respiratory distress. He had fever, a nonproductive cough, and myalgias. On admission to this hospital, he was hypoxemic. Respiratory failure, renal failure, and hypotension developed.
Full Text [...]
Some Intranasal H1N1 Vaccine Recalled over Potency Concerns
MedImmune is recalling 13 lots — some 4.7 million doses — of its intranasal 2009 H1N1 vaccine over concerns that the vaccine may lose potency as it sits on the shelf, according to the company.
More in this category
- One Dose of H1N1 Vaccine May Be Enough for Children
- Neuraminidase Inhibitors Have Only ‘Modest Effectiveness’ in Otherwise Healthy Adults with Flu
- H1N1 Vaccine Safety ‘Reassuring’
- ECMO for Patients with 2009 H1N1 Influenza and ARDS
- Estimates of Flu’s Toll; Seasonal Vaccine Not Effective Against 2009 H1N1
- CDC Releases ‘Quick Facts’ for Providers on Antiviral Drug Use
